Previous 10 | Next 10 |
2023-09-15 15:00:00 ET More on the markets Key Region Of Support Sides With SPY Bullish Case Market Crosswinds And Nasdaq Looking Better Than Dow The Fed's rate-hike cycle has 'most assuredly ended' -- Lawrence Fuller Fund managers finally embrace U.S. stocks...
ATLANTA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Outlook Therapeutics, Inc. (“Outlook Therapeutics” or “the Company”) (NASDAQ: OTLK) complied with federal securities laws. On August 30, 2023, Outlook Therapeutics announced t...
2023-09-08 15:00:57 ET More on the markets The Unemployment Rate Just Signaled That A Recession May Occur Within The Next 6 Months High Yield Signal Does Not Align With Bearish Outlook For SPY SPY: The Calm Before The Storm Bulls vs. Bears: SA analysts weigh ...
ISELIN, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced that Russell Trenary, President an...
2023-09-01 15:00:48 ET More on the markets My Current View Of The S&P 500 Index: September 2023 Edition The 'Big Short' Ignores Buffett And Bets Big On A Selloff: SPY Implications Is The Market Ignoring Signs Of An Imminent Debt Crisis? For further detail...
2023-08-30 13:16:02 ET Gainers: NanoVibronix ( NAOV ) +127% . iCoreConnect ( ICCT ) +49% . Aravive ( ARAV ) +35% . AEON Biopharma ( AEON ) +33% . Alarum Technologies ( ALAR ) +25% . Greenland Technologies Holding Corporation ...
2023-08-30 10:00:13 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half XLV Vs. VHT: A Head-To-Head Healthcare ETF C...
2023-08-30 08:24:12 ET Outlook Therapeutics ( OTLK ) -78% . FibroGen ( FGEN ) -23% announces topline results from LELANTOS-2, a phase 3 clinical study of Pamrevlumab. Ambarella ( AMBA ) -20% after Q2 earning release . MasterCraft Boat Holdings (...
2023-08-30 06:48:29 ET More on Outlook Therapeutics Outlook Therapeutics: August PDUFA May Be A Buy With Some Caveats Outlook draws bullish views at Cantor on potential FDA nod for lead asset Outlook Therapeutics GAAP EPS of -$0.31 in-line Outlook enters defi...
FDA issues Complete Response Letter (CRL) for ONS-5010 BLA based on CMC and need for further confirmatory clinical evidence Outlook Therapeutics working with FDA to address the Agency’s issues Company to host conference call and webcast, today, August 30 at 8:30 AM ET ...
News, Short Squeeze, Breakout and More Instantly...
Outlook Therapeutics Inc. Company Name:
OTLK Stock Symbol:
NASDAQ Market:
Outlook Therapeutics Inc. Website:
2024-07-16 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
UK MHRA marketing authorization follows recent European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) in the EU for the treatment of wet AMD Initial commercial launches of LYTENAVA™ (bevacizumab gamma) in the EU and UK anticipated in calendar Q1 2025...